抑郁症家族风险中的壳核结构与功能:多模态影像研究
本研究纳入115名根据第一代是否患重性抑郁障碍而定义的高或低家族风险的二代、三代子代,采用结构MRI、质子磁共振波谱(NAA/Cr比值)和功能MRI纵向评估壳核。高-risk个体壳核体积、NAA/Cr比值及效价调制激活均低于低-risk个体,且较低壳核体积可预测扫描后长达8年的重性抑郁发作。
要点
- 高家族风险子代壳核体积(β左=-0.17,β右=-0.15,ps=.002)低于低风险子代。
- 高家族风险子代壳核NAA/Cr比值(β左=-0.40,β右=-0.37,ps<.0001)低于低风险子代。
- 较低壳核体积预测扫描后8年内重性抑郁发作(β左=-0.72,p=.013;β右=-0.83,p=.037)。
核心结论
- 高重性抑郁障碍家族风险个体存在壳核结构与功能异常,壳核可能是抑郁疾病的潜在生物标志物。
研究设计与样本
- 研究纳入115名按第一代有无重性抑郁障碍定义的高或低家族风险二代、三代子代,纵向随访采用盲于家族风险半结构化临床访谈。
- 壳核结构、神经元完整性和功能激活分别通过结构MRI、质子磁共振波谱(NAA/Cr比值)和 mood induction 任务中效价与唤醒调制的功能MRI评估。
主要发现
- 调整协变量后,高-risk个体壳核体积低于低-risk个体(标准化β左=-0.17,β右=-0.15,ps=.002)。
- 高-risk个体壳核NAA/Cr比值低于低-risk个体(β左=-0.40,β右=-0.37,ps<.0001)。
- 高-risk个体效价调制激活低于低-risk个体(β左=-0.22,β右=-0.27,ps<.05)。
- 体积差异在较年轻年龄更大,NAA/Cr比值差异在较年长年龄更大。
- 较低壳核体积预测扫描后长达8年的重性抑郁发作(β左=-0.72,p=.013;β右=-0.83,p=.037),磁共振波谱与任务功能MRI测量呈 modest 相关(0.27≤r≤0.33)。
临床怎么用
- 原文指出未来研究应关注壳核作为抑郁疾病的潜在生物标志物。
- 原文同时指出,归因于家族史的差异可能因所用MRI模态不同而在不同年龄达到峰值。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The putamen has been implicated in depressive disorders, but how its structure and function increase depression risk is not clearly understood. Here, we examined how putamen volume, neuronal density, and mood-modulated functional activity relate to family history and prospective course of depression. METHODS: The study includes 115 second- and third-generation offspring at high or low risk for depression based on the presence or absence of major depressive disorder in the first generation. Offspring were followed longitudinally using semistructured clinical interviews blinded to their familial risk; putamen structure, neuronal integrity, and functional activation were indexed by structural magnetic resonance imaging (MRI), proton magnetic resonance spectroscopy (N-acetylaspartate/creatine ratio), and functional MRI activity modulated by valence and arousal components of a mood induction task, respectively. RESULTS: After adjusting for covariates, the high-risk individuals had lower putamen volume (standardized betas, β-left = -0.17, β-right = -0.15, ps = .002), N-acetylaspartate/creatine ratio (β-left= -0.40, β-right= -0.37, ps < .0001), and activation modulated by valence (β-left = -0.22, β-right = -0.27, ps < .05) than low-risk individuals. Volume differences were greater at younger ages, and N-acetylaspartate/creatine ratio differences were greater at older ages. Lower putamen volume also predicted major depressive disorder episodes up to 8 years after the scan (β-left = -0.72, p = .013; β-right = -0.83, p = .037). Magnetic resonance spectroscopy and task functional MRI measures were modestly correlated (0.27 ≤ r ≤ 0.33). CONCLUSIONS: Findings demonstrate abnormalities in putamen structure and function in individuals at high risk for major depressive disorder. Future studies should focus on this region as a potential biomarker for depressive illness, noting meanwhile that differences attributable to family history may peak at different ages based on which MRI modality is being used to assay them.
引用
- Talati A, van Dijk MT, Pan L, et al. Putamen Structure and Function in Familial Risk for Depression: A Multimodal Imaging Study. Biol Psychiatry. 2022. PMID: 36038379. doi:10.1016/j.biopsych.2022.06.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。